Development of a novel multi-epitope vaccine against Ureaplasma urealyticum infection through reverse vaccinology approach
Molecular Diversity · 2026
DOI: 10.1007/s11030-025-11234-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2026. Verfasst von Linglan Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Clinical Medical Research Center for Occupational Diseases, Hunan Prevention and Treatment Institute for Occupational Diseases, Affili…. Hauptthemen laut MEDLINE: Bacterial Vaccines, Ureaplasma urealyticum, Epitopes, B-Lymphocyte, Epitopes, T-Lymphocyte. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Ureaplasma urealyticum (U. urealyticum) is a sexually transmitted pathogen often causing urogenital tract disorders. The growing challenge of multidrug-resistant strains poses a significant risk for the treatment of U. urealyticum infections. To date, no licensed vaccines are available, and previous attempts to create secure and efficient prophylaxis have been failed. Recent studies have adopted an immunoinformatic strategy based on reverse vaccinology to detect antigenic proteins which are appropriate for the creation of a multi-epitope vaccine. The multi-epitope subunit vaccine, incorporating eleven T-cell and seven B-cell epitopes along with the adjuvant, exhibited strong antigenicity and did not induce allergic responses. Moreover, molecular docking as well as dynamic simulations were utilized to investigate the interaction within the vaccine-adjuvant complex. The prospective effectiveness of the vaccine was verified via immune simulation experiments. Therefore, the vaccine developed in this study represents an effective multi-epitope solution for immunization against U. urealyticum, waiting for further experimental analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Province Clinical Medical Research Center for Occupational Diseases, Hunan Prevention and Treatment Institute for Occupational Diseases, Affiliated Prevention and Treatment Institute for Occupational Diseases of U…
- Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, 421001, Hunan, China.
- Institute of Pathogenic Biology, School of Basic Medicine, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang Medical College, University of South China, Hengyang, Hunan, China.
- Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, 421001, Hunan, China. zhengkang1221@sina.com.
- Institute of Pathogenic Biology, School of Basic Medicine, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hengyang Medical College, University of South China, Hengyang, Hunan, China. liran…
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xu, L., Xie, N., Liu, Y., Tang, H., He, J., He, Z., Zheng, K., & Li, R. (2026). Development of a novel multi-epitope vaccine against Ureaplasma urealyticum infection through reverse vaccinology approach. Molecular Diversity. https://doi.org/10.1007/s11030-025-11234-2
Vancouver
Xu L, Xie N, Liu Y, Tang H, He J, He Z, et al. Development of a novel multi-epitope vaccine against Ureaplasma urealyticum infection through reverse vaccinology approach. Molecular Diversity. 2026. doi:10.1007/s11030-025-11234-2
BibTeX
@article{Xu2026,
author = {Xu, Linglan and Xie, Nan and Liu, Yiqin and Tang, Hongmei and He, Jinjiang and He, Zhen and Zheng, Kang and Li, Ranhui},
title = {Development of a novel multi-epitope vaccine against Ureaplasma urealyticum infection through reverse vaccinology approach},
journal = {Molecular Diversity},
year = {2026},
doi = {10.1007/s11030-025-11234-2}
}
EUVIMED